Importer of Controlled Substances; Notice of Registration, 64672 [E7-22512]
Download as PDF
<![CDATA[
64672
Federal Register / Vol. 72, No. 221 / Friday, November 16, 2007 / Notices
fire in the test area. In response, EPA
determined that a cut off wall should be
substituted for the in-situ stabilization
approach to the wastewater ponds. The
Amendment modifies the original
Consent Decree to ensure that this
remedy modification is enforceable.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the First Amendment to
Consent Decree. Comments should be
addressed to the Assistant Attorney
General, Environmental and Natural
Resources Division, and either e-mailed
to pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States v. Stauffer Management
Company LLC and Bayer CropScience
Inc., D.J. Ref. 90–11–2–1227/3.
The First Amendment to Consent
Decree may be examined at the Office of
the United States Attorney, 400 North
Tampa Street, Suite 3200, Tampa,
Florida 33602, and at U.S. EPA Region
4, 61 Forsyth Street, Atlanta, Georgia
30303–8960. During the public
comment period, the First Amendment
to Consent Decree, may also be
examined on the following Department
of Justice Web Site, to https://
www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
First Amendment to Consent Decree
may also be obtained by mail from the
Consent Decree Library, P.O. Box 7611,
U.S. Department of Justice, Washington,
DC 20044–7611 or by faxing or emailing a request to Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax no.
(202) 514–0097, phone confirmation
number (202) 514–1547. In requesting a
copy from the Consent Decree Library,
please enclose a check in the amount of
$3.50 (25 cents per page reproduction
cost) payable to the U.S. Treasury or, if
by e-mail or fax, forward a check in that
amount to the Consent Decree Library at
the stated address.
Henry Friedman,
Assistant Chief, Environmental Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. 07–5693 Filed 11–15–07; 8:45 am]
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated July 31, 2007 and
published in the Federal Register on
August 9, 2007, (72 FR 44859), Almac
Clinical Services Inc., (ACSI), 2661
Audubon Road, Audubon, Pennsylvania
19403, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in schedule II:
Drug
Schedule
Oxycodone (9143) ........................
Fentanyl (9801) ............................
II
II
The company plans to import small
quantities of the listed controlled
substances in dosage form to conduct
clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Almac Clinical Services Inc. to import
the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Almac Clinical Services
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: November 6, 2007.
Joseph T. Rannazzisi,
Deputy Assistant, Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–22512 Filed 11–15–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated July 10, 2007, and
published in the Federal Register on
July 24, 2007, (72 FR 40331), American
Radiolabeled Chemical, Inc., 101 Arc
Drive, St. Louis, Missouri 63146, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule I and II:
mstockstill on PROD1PC66 with NOTICES
Drug
Schedule
Gamma hydroxybutyric acid (2010) ............................................................................................................................................................
Ibogaine (7260) ...........................................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
Dihydromorphine (9145) ..............................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Amobarbital (2125) ......................................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Phenylacetone (8501) .................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Hydrocodone (9193) ....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Metazocine (9240) .......................................................................................................................................................................................
VerDate Aug<31>2005
21:48 Nov 15, 2007
Jkt 214001
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
E:\FR\FM\16NON1.SGM
16NON1
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 72, Number 221 (Friday, November 16, 2007)]
[Notices]
[Page 64672]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-22512]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated July 31, 2007 and published in the Federal Register
on August 9, 2007, (72 FR 44859), Almac Clinical Services Inc., (ACSI),
2661 Audubon Road, Audubon, Pennsylvania 19403, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as an importer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Oxycodone (9143)........................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances in dosage form to conduct clinical trials.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Almac Clinical Services Inc. to import the basic
classes of controlled substances is consistent with the public interest
and with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this time. DEA
has investigated Almac Clinical Services Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: November 6, 2007.
Joseph T. Rannazzisi,
Deputy Assistant, Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-22512 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P
